LI
DNTH icon

LRI Investments’s Dianthus Therapeutics DNTH Stock Holding History

LRI Investments’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Sell
331
-136
-29% -$11.9K ﹤0.01% 635
2026
Q1 		$39.2K Buy
+467
New +$27K ﹤0.01% 554

Other funds holding DNTH

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LRI Investments's DNTH Position: Q2 2026 in Review

LRI Investments reduced its Dianthus Therapeutics (DNTH) stake by 29% in Q2 2026, selling an estimated $11.9K and leaving 331 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

LRI Investments first reported a position in DNTH in Q1 2026 and has held it in 2 quarters since. The position peaked at $39.2K in Q1 2026. 33 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • LRI Investments held 331 shares of Dianthus Therapeutics worth $32.2K as of Q2 2026.
  • LRI Investments sold 136 Dianthus Therapeutics shares in Q2 2026, an estimated $11.9K.
  • Dianthus Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #635 holding.
  • LRI Investments first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • LRI Investments's Dianthus Therapeutics position peaked at $39.2K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.